Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
BACKGROUND: We examined the strategy of T-cell depletion of HLA-identical sibling grafts for the prevention of GvHD, as well as disease control and overall survival. PATIENTS AND METHODS: The myeloablative conditioning was radiation based. The source of stem cells was BM in 62, and cytokine-mobiliz...
Auteurs principaux: | Novitzky, N, Thomas, V, Hale, G, Waldmann, H |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2004
|
Documents similaires
-
Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
par: Novitzky, N, et autres
Publié: (2003) -
T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
par: Novitzky, N, et autres
Publié: (2004) -
COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
par: Fibbe, W, et autres
Publié: (1993) -
CAMPATH-1 antibodies in stem-cell transplantation.
par: Hale, G, et autres
Publié: (2001) -
T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
par: Novitzky, N, et autres
Publié: (1997)